Results from two clinical trials showed that a once-weekly version of insulin de...
After the disappointing outcome of early-stage trials for their antisense drug B...
Recently, the U.S. Food and Drug Administration (FDA) approved Imdelltra, a new ...
The rapidly developing area of pulsed field ablation is gaining momentum all ove...
The U.S. health regulator, FDA, has now allowed Eisai and Biogen to provide data...
Roche, one of the first companies to provide an HPV self-collection option in th...
The FDA has given the go-ahead for Bristol Myers Squibb’s Breyanzi – a cancer ce...
MacroGenics’s safety concerns have continued throughout phase 2 of the project. ...
The Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) research study, which aimed to t...
As France prepares for its annual ‘Choose France’ business summit, the pharmaceu...
Founded by two college friends, Hrituraj Singh and Sarim Khan, Triomics is an ar...
Johnson & Johnson published its Phase IIb SunRISe-1 trial update, revealing the ...
Gossamer Bio, a clinical-stage biopharmaceutical company, announced its collabor...
A young child with Duchenne muscular dystrophy (DMD) participating in Pfizer’s P...
With its newest $1 billion deal with Marina Oncology, Novartis moves one step cl...
Roughly one in every 12 pregnancies is estimated to be affected by preeclampsia,...
